Home News & Events Events

Future Events

21st Training Course on Hemopoietic Stem Cell Transplantation

As a sponsor in 2017, Kiadis Pharma will support the ESH-EBMT 21st Training Course on Haemopoietic Stem Cell Transplantation to take place on May 04 – May 06, 2017 – Saggart (Dublin), IRELAND.

Every year, the ESH-EBMT Training Course provides a comprehensive training in all aspects of autologous and allogeneic stem cell transplantation and comprises a mixture of formal lectures, case presentations by attendees and faculty, meet-the-expert breakfasts and dinner table discussions. For each topic an explanation of the basic principles is provided, followed by development of the subject through to the most recent advances in understanding and management. The objective of the course is to give opportunity to the attendees to have close contact and lively interaction with the teachers and the group in a nice setting.

4 - 6, May, 2017, Dublin, Ireland

25th International Society of Cellular Therapy (ISCT)

Kiadis Pharma’s abstract has been selected by the International Society for Cellular Therapy (ISCT) as a Late Breaking Abstract for an oral presentation at the 2017 Annual Meeting in London, United Kingdom on May 4, 2017.

The abstract provides key clinical data from the Company’s international multi-center trial on the improvement of event-free survival (GRFS) and overall survival in patients treated with ATIR101™ as part of their transplant regimen. The last update on this trial was presented at the ASH meeting in December 2016. The abstract will be presented by Dr. Halvard Bönig, Professor for Translational Development of Cellular Therapeutics at the Johann-Wolfgang-Goethe University and Head of the Department of Cellular Therapeutics / Cell Processing (GMP) of the German Red Cross Blood Donor Service, Baden-Wuerttemberg-Hessen, which manufactures the Company’s lead product ATIR101™ for Europe.

Date: Thursday May 4, 2017 between 15:30 and 17:00 BST
Abstract title: Add back of selectively depleted alloreactive T-cells retaining the full immune repertoire of mature T-cells improves event-free survival (GRFS) and overall survival in a T-cell depleted haploidentical HSCT
Presenting author: Dr. Halvard Bönig
Abstract number: LB01
Location: ExCeL London

The abstract is scheduled to be available at the Company’s website on Thursday May 4, 2017. In addition, the abstract will be published in the online version of Cytotherapy, the official journal of ISCT.

3 - 6, May, 2017, London, United Kingdom